Anticoagulant Adverse Reaction Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting anticoagulant adverse reaction clinical trials across 8 countries. Studies span Phase 4, Not Applicable. Top locations include Aarhus, Region Midt, Denmark, Addis Ababa, Ethiopia, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Anticoagulant Adverse Reaction Trials at a Glance

7 actively recruiting trials for anticoagulant adverse reaction are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 4 with 3 trials, with the heaviest enrollment activity in Aarhus, Addis Ababa, and Beijing. Lead sponsors running anticoagulant adverse reaction studies include Clinique Pasteur, Helse Nord-Trøndelag HF, and China National Center for Cardiovascular Diseases.

Browse anticoagulant adverse reaction trials by phase

Treatments under study

About Anticoagulant Adverse Reaction Clinical Trials

Looking for clinical trials for Anticoagulant Adverse Reaction? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anticoagulant Adverse Reaction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anticoagulant Adverse Reaction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

SarcopeniaUltrasonographyAcute-On-Chronic Liver Failure+1 more
University Hospital, Antwerp20 enrolled1 locationNCT06079021
Recruiting
Not Applicable

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

Benign Prostatic HyperplasiaAnticoagulant Adverse Reaction
Clinique Pasteur389 enrolled1 locationNCT03297281
Recruiting

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

Neuromuscular Diseases (NMD)PolyneuropathiesPeripheral Neuropathies+4 more
Masaryk University70 enrolled2 locationsNCT07166302
Recruiting

The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa

Rheumatic heart diseaseAnticoagulant Adverse Reaction
Helse Nord-Trøndelag HF200 enrolled4 locationsNCT04556188
Recruiting
Phase 4

Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation

Atrial FibrillationStrokeAnticoagulant Adverse Reaction+1 more
China National Center for Cardiovascular Diseases4,374 enrolled1 locationNCT06108414
Recruiting
Phase 4

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

Atrial FibrillationAnticoagulant Adverse ReactionLeft Atrial Appendage Absent
Odense University Hospital1,220 enrolled6 locationsNCT06401616
Recruiting
Phase 4

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation

Atrial FibrillationAnticoagulant Adverse Reaction
Korea University Anam Hospital940 enrolled1 locationNCT06187311